Clinical Trial Update: Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes a Phase 1/2 pharmacokinetic study comparing subcutaneous versus intravenous palonosetron for chemotherapy-induced nausea and vomiting in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Emesis | Phase 1, Phase 2 | Status: COMPLETED